Registration

GEPHARDT GROUP GOVERNMENT AFFAIRS for HEALIANCE PHARMACEUTICALS

Firm
Client
Income
—
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Foreign Relations FOR

innovative diabetes treatment

LobbyistCovered position, as disclosed
JANICE O'CONNELL New Prof Staff, Senate Baking and Foreign Relations Committees

Pharmacy PHA

innovative diabetes treatment

LobbyistCovered position, as disclosed
JANICE O'CONNELL New Prof Staff, Senate Baking and Foreign Relations Committees

Health Issues HCR

innovative diabetes treatment

LobbyistCovered position, as disclosed
JANICE O'CONNELL New Prof Staff, Senate Baking and Foreign Relations Committees

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
DIGEN PHARMACEUTICALS GMBH Austria Austria 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.